Rising Prevalence of Hypertension Fuels Angiotensin Receptor Antagonists Market to Register a CAGR of 3.6% and Reach US $12.0 Billion by 2032

4 minutes, 37 seconds Read

Report Summary:

The global angiotensin receptor antagonists market is poised for significant growth, with a projected value of US$ 12.0 billion by 2032 and a steady compound annual growth rate (CAGR) of 3.6%. This expansion is primarily driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Angiotensin receptor antagonists, known for their efficacy and safety, have become popular treatment options. The market’s growth is further fueled by factors such as the aging population, sedentary lifestyles, and rising awareness regarding the management of hypertension. The market is segmented based on drug type, distribution channel, and geography, reflecting the diverse needs and preferences of patients and healthcare providers.

Get a sample research report here


** Note – Updated Version 2023 Includes:

‣ Brief Overview to the research study.

‣ Table of Contents the scope of the study’s coverage

‣ Leading market participants

‣ Structure of the report’s research framework

‣ Prophecy Market Insights research approach

Market Overview:

The angiotensin receptor antagonists market is experiencing rapid growth globally, driven by factors such as the increasing prevalence of hypertension, the aging population, lifestyle changes, and growing awareness of cardiovascular health. These medications play a crucial role in managing hypertension and related cardiovascular conditions, offering proven efficacy, tolerability, and fewer side effects. Developed regions and emerging markets both present significant growth opportunities due to their respective healthcare infrastructures and the rising burden of hypertension. As healthcare providers and patients recognize the benefits of angiotensin receptor antagonists in effectively managing blood pressure and reducing cardiovascular risks, the market is expected to continue expanding in the foreseeable future.

Scope of Angiotensin Receptor Antagonists Market:

The scope of the angiotensin receptor antagonists market is vast and encompasses various factors, including the increasing prevalence of hypertension and related cardiovascular diseases, the aging population, lifestyle changes, and the growing demand for effective antihypertensive medications. This market involves the production, distribution, and sales of angiotensin receptor antagonist drugs, which play a crucial role in managing hypertension, heart failure, and certain kidney conditions. With a global reach, the market offers opportunities in both developed and emerging regions, driven by the need for efficient pharmaceutical interventions to control blood pressure and prevent cardiovascular complications. As awareness regarding the benefits of angiotensin receptor antagonists continues to grow, the market is expected to witness significant expansion and innovation in the coming years.

Major companies in Angiotensin Receptor Antagonists Market are:

  • Pfizer, Inc.
  • Novartis AG
  • Merck & Co., Ltd.
  • Astra Zeneca Pharmaceuticals LP
  • Jhonson and Johnson AG
  • Eli Lilly and Company
  • Sanofi SA
  • Bristol-Myers Squibb Co.
  • Bayer AG
  • Teva Pharmaceutical, Inc.

– Additionally, the report covers the fundamental variables impacting market growth as well as the opportunities, challenges, and dangers that the major competitors and the industry as a whole face. The impact of significant new developments on current and future growth is also examined.

Geographical Outlook:

➡ North America (U.S., Canada, Mexico)

➡ Europe (U.K., Italy, Germany, Russia, France, Spain, the Netherlands and Rest of Europe)

➡ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

➡ Latin America (Colombia, Brazil, Argentina, Rest of Latin America)

➡ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Create Your Own Individual Style and Order a Custom Report!


Key Insights:

  • Growing Prevalence of Hypertension: The increasing prevalence of hypertension globally is a major driving factor for the angiotensin receptor antagonists market. Hypertension is a common cardiovascular condition that requires long-term management, creating a sustained demand for these medications.
  • Rising Cardiovascular Disease Burden: Cardiovascular diseases, including hypertension, heart failure, and related conditions, pose a significant health burden worldwide. Angiotensin receptor antagonists play a crucial role in managing these conditions, contributing to the market’s growth.
  • Favorable Efficacy and Safety Profile: Angiotensin receptor antagonists are known for their efficacy in reducing blood pressure and improving cardiovascular outcomes. They are generally well-tolerated and have a lower incidence of side effects compared to some other antihypertensive medications, making them a preferred choice for physicians and patients.
  • Aging Population and Lifestyle Factors: The aging population, along with sedentary lifestyles, unhealthy diets, and stress, contributes to the increased incidence of hypertension and cardiovascular diseases. These demographic and lifestyle factors drive the demand for angiotensin receptor antagonists.

Overall, the angiotensin receptor antagonists market is driven by the growing prevalence of hypertension and cardiovascular diseases, favorable efficacy and safety profiles of these medications, aging population, lifestyle factors, technological advancements, expanding emerging markets, and strategic collaborations among key players.

Reasons to Buy the Report:

  • Thorough examination of the market at the international and local levels.
  • Significant changes in the competitive environment and market dynamics.
  • Classification based on kind, application, locality, and other factors.
  • Market analysis of the past and the future in terms of size, share expansion, volume, and sales.
  • Significant adjustments and evaluations of market dynamics and trends.
  • Regions and emerging important segments
  • Major market participants’ core business strategies and techniques.

About Prophecy Market Insights                                                                                                               

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:


Prophecy Market Insights

U.S.  +1 860 531 2574

RoW:  +91 7775049802

Email- mailto:sales@prophecymarketinsights.com

To find out more, visit www.prophecymarketinsights.com

Blog: prophecyjournals.com/

Follow us on TwitterLinkedInYouTube and Facebook

Your Missed